AI-powered
General interest for COVID-19 research information
Investigation of the Efficacy of an Investigational Drug in Treating Chronic Pain
Enrolling By Invitation
18 years - 100 years
All
Phase
N/A
1 Location
Brief description of study.
We are dedicated to improving the lives of Hoosiers by providing information, news, and stories related to COVID-19 research in Indiana.
If you are interested in hearing more about COVID-19 research, please complete your volunteer profile here. Also, be sure to join All IN for Health's online community to receive our twice-monthly e-update.
Detailed description of study
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: corona virus,family,COVID 19,healthy,COVID,corona,virus,coronavirus,COVID19,test,home,children
-
Age: 18 years - 100 years
-
Gender: All
Updated on
19 Feb 2024.
Study ID: NA1234567
- Who can participate: Participants aged 18 to 65 years with a diagnosis of chronic pain for at least six months are eligible. Key exclusions include individuals with a history of drug abuse or those currently using other investigational treatments.
- Study details: Participants will be randomly assigned to receive either the investigational drug or a placebo. The study will involve regular assessments of pain levels and quality of life through questionnaires and clinical evaluations.
If you need help finding a study or have any questions, please contact us
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
